Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
34301
Data Sheet 1_Identification of a multiple DAMP scavenger mimicking the DAMP-binding site of TLR4 to ameliorate lethal sepsis.pdf
Published 2025“…OP18 was developed by identifying a 15-amino acid (aa) binding site within the extracellular domain of Toll-like receptor 4 (TLR4) shared by eCIRP, HMGB1, and histone H3, then extending it with an α<sub>v</sub>β<sub>3</sub>-integrin binding RGD (Arg-Gly-Asp) motif, resulting in an 18-aa peptide. …”
-
34302
-
34303
-
34304
-
34305
Correlation between the RS rate and temperature.
Published 2025“…The experimental results showed that low nitrogen addition rate (5 g·m<sup>-2</sup>·yr<sup>-1</sup>) increased soil respiration rate by about 11% in summer, but decreased it by about 6% in winter, with a range of 5% to 20%. …”
-
34306
Schematic diagram of experimental area selection.
Published 2025“…The experimental results showed that low nitrogen addition rate (5 g·m<sup>-2</sup>·yr<sup>-1</sup>) increased soil respiration rate by about 11% in summer, but decreased it by about 6% in winter, with a range of 5% to 20%. …”
-
34307
Influence of N-addition on soil RH.
Published 2025“…The experimental results showed that low nitrogen addition rate (5 g·m<sup>-2</sup>·yr<sup>-1</sup>) increased soil respiration rate by about 11% in summer, but decreased it by about 6% in winter, with a range of 5% to 20%. …”
-
34308
Image_1_Biosynthesis of Silver Nanoparticles by Marine Actinobacterium Nocardiopsis dassonvillei and Exploring Their Therapeutic Potentials.jpg
Published 2022“…In vitro studies using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay revealed a concentration-dependent decrease in cell viability when CaCo2 cells were exposed to Bio-AgNPs. …”
-
34309
DataSheet1_Voluntary wheel running reduces tumor growth and increases capillarity in the heart during doxorubicin chemotherapy in a murine model of breast cancer.pdf
Published 2024“…Two weeks later, doxorubicin treatment was started via intraperitoneal administration (5 mg/kg weekly for 3 weeks). Organs were harvested a day after the last dose.…”
-
34310
Image4_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG
Published 2024“…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
-
34311
Image6_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG
Published 2024“…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
-
34312
Image3_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG
Published 2024“…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
-
34313
Table2_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.DOCX
Published 2024“…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
-
34314
Image1_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG
Published 2024“…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
-
34315
Table4_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.docx
Published 2024“…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
-
34316
Image2_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG
Published 2024“…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
-
34317
Image7_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG
Published 2024“…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
-
34318
Table3_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.docx
Published 2024“…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
-
34319
Table1_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.docx
Published 2024“…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
-
34320